Skip to main
CNXC

CNXC Stock Forecast & Price Target

CNXC Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Concentrix Corp is projected to experience improved revenue and non-GAAP EPS growth in fiscal years 2026 and 2027, driven by gains in market share and wallet share along with a strategic shift towards high-value solutions. The banking sector, a key area for the company, is anticipated to continue its robust growth trajectory, with increases expected in the high-single-digit to low-double-digit range across various financial institutions. Additionally, the company's technology solutions have shown significant traction, with technology wins rising by 61% year-over-year in fiscal Q1/26, indicating strong client acceptance and a shift in the go-to-market strategy.

Bears say

Concentrix Corp's financial performance has shown a concerning decline in key profitability metrics, with adjusted EBITDA margins falling year-over-year from 15.8% and sequentially from 14.8% to 13.9% in fiscal Q1/26. Additionally, the company's gross margins have decreased from 36.1% year-over-year and sequentially from 34.3% to 34.0%, indicating ongoing pressure on profitability. Moreover, challenges in core sectors, particularly healthcare, have contributed to an anticipated 6% year-over-year decline in adjusted EPS, compounded by unfavorable tax rate adjustments and continued headwinds from reduced Medicare enrollment.

CNXC has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Concentrix Corporation (CNXC) Forecast

Analysts have given CNXC a Buy based on their latest research and market trends.

According to 4 analysts, CNXC has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Concentrix Corporation (CNXC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.